King Pharmaceuticals Reaches $38M Settlement
Hoping to bring an end to a securities class action suit, drug company King Pharmaceuticals Inc. reached a $38.25 million settlement deal on Friday....To view the full article, register now.
Already a subscriber? Click here to view full article